UF Health Researcher Explains Herd Immunity and How It Could End COVID-19 Pandemic
Cindy A. Prins, Ph.D., M.P.H., a University of Florida Health infectious disease epidemiologist who is an associate professor in the UF College of Public Health and Health Professions and the UF College of Medicine, looks at herd immunity and explains how it might be part of the answer.
DiaCarta’s Novel XNA Technology Rapidly Detects Raging New SARS-CoV-2 Variants
UF Innovate | Sid Martin Biotech alum DiaCarta Inc. announced the publication of a study to rapidly detect new COVID-19 variants in MedRxiV.
‘One Billion Doses On Day One’: Vaccine Company Claims World-Changing Innovation
Curious about what motivates the company that just acquired UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices? Anger at the length of time it is taking to get vaccines to fight Covid. This story in Forbes is a picture of Resilience, a new player in the town of Alachua.
UF Health Study Will Examine Drugs To Treat Coronavirus UK Variant
Researchers say they aren't surprised by the coronavirus's ability to mutate, but they are working on ways to stop the spread. UF Associate Professor of Pathology David A. Ostrov's discovery about the UK variant has identified 40 candidate drugs that could serve as additional tools in the fight against COVID.
Tampa Bay Company Searching for Other Vaccine Methods
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc., a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, is in the pre-clinical phase of developing a vaccine they say would solve two critical problems when it comes to ending the pandemic.
Evolugate Improves DNA-Plasmid Production, Ready To Impact COVID-19 Vaccines Manufacturing Throughput
UF startup Evolugate, LLC, a Gainesville-based biotech company, has demonstrated that its proprietary technology can be used to improve the throughput of plasmid DNA manufacturing.
Everything You Need To Know About Vaccines and COVID-19
Dr. Peter Khoury, president and CEO of UF startup and UF Innovate | Sid Martin Biotech graduate Ology Bioservices, Inc., a biologics contract development and manufacturing organization (CDMO), talked with James Di Virgilio, Radio Cade's host, about vaccinations and COVID-19.
Oragenics Chases Vaccine for Niche Markets
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, a leader in the development of new antibiotics against infectious diseases and effective treatments for oral mucositis, seeks to be a major player in the Super Bowl of the pharmaceutical industry: a COVID-19 vaccine.
Biotech Firm Raises $20 Million, Sees Progress on COVID-19 Vaccine
UF startup and UF Innovate | Sid Martin Biotech graduate company Oragenics, Inc. has raised $20 million from the sale of common stock and will use some of the funding to boost its research into a Covid-19 vaccine.
Dr. Cindy Prins Assesses Spaces Across UF Campus for COVID-19 Transmission Risks
In her role as the infection preventionist for the UF Health Screen, Test and Protect Program, Cindy Prins, Ph.D., clinical associate professor of epidemiology and assistant dean for educational affairs for the UF College of Public Health and Health Professions, offers infection control assessments for UF entities who aim to resume activities throughout campus.